Neogen Corp (NEOG)
13.72
+0.54
(+4.14%)
USD |
NASDAQ |
Jun 03, 16:00
13.72
0.00 (0.00%)
After-Hours: 18:32
Neogen Debt to Equity Ratio: 0.2821 for Feb. 29, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
February 29, 2024 | 0.2821 |
November 30, 2023 | 0.2818 |
August 31, 2023 | 0.2817 |
May 31, 2023 | 0.2825 |
February 28, 2023 | 0.2831 |
November 30, 2022 | 0.2975 |
August 31, 2022 | 0.00 |
May 31, 2022 | 0.00 |
February 28, 2022 | 0.00 |
November 30, 2021 | 0.00 |
August 31, 2021 | 0.00 |
May 31, 2021 | 0.00 |
February 28, 2021 | 0.00 |
November 30, 2020 | 0.00 |
August 31, 2020 | 0.00 |
May 31, 2020 | 0.00 |
February 29, 2020 | 0.00 |
November 30, 2019 | 0.00 |
August 31, 2019 | 0.00 |
May 31, 2019 | 0.00 |
February 28, 2019 | 0.00 |
November 30, 2018 | 0.00 |
August 31, 2018 | 0.00 |
May 31, 2018 | 0.00 |
February 28, 2018 | 0.00 |
Date | Value |
---|---|
November 30, 2017 | 0.00 |
August 31, 2017 | 0.00 |
May 31, 2017 | 0.00 |
February 28, 2017 | 0.00 |
November 30, 2016 | 0.00 |
August 31, 2016 | 0.00 |
May 31, 2016 | 0.00 |
February 29, 2016 | 0.00 |
November 30, 2015 | 0.00 |
August 31, 2015 | 0.00 |
May 31, 2015 | 0.00 |
February 28, 2015 | 0.00 |
November 30, 2014 | 0.00 |
August 31, 2014 | 0.00 |
May 31, 2014 | 0.00 |
February 28, 2014 | 0.00 |
November 30, 2013 | 0.00 |
August 31, 2013 | 0.00 |
May 31, 2013 | 0.00 |
February 28, 2013 | 0.00 |
November 30, 2012 | 0.00 |
August 31, 2012 | 0.00 |
May 31, 2012 | 0.00 |
February 29, 2012 | 0.00 |
November 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Aug 2019
0.2975
Maximum
Nov 2022
0.0899
Average
--
Median
Aug 2019
Debt to Equity Ratio Benchmarks
Moderna Inc | 0.00 |
Regeneron Pharmaceuticals Inc | 0.0735 |
Syros Pharmaceuticals Inc | -- |
Disc Medicine Inc | -- |
Amylyx Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 4.582B |
Total Liabilities (Quarterly) | 1.436B |
Shareholders Equity (Quarterly) | 3.146B |
Current Ratio | 3.817 |
Net Debt Paydown Yield | 0.20% |